Explained — Why shares of Neuland, Divis and other pharma shares fall up to 9%

The fall comes after the US Biosecure Act was kept out of a key defence bill, in what marked a win for Chinese Biotech.

Leave a Reply

Your email address will not be published. Required fields are marked *